Navigation Links
BD Announces Results for Third Fiscal Quarter
Date:7/24/2008

p> Pharmaceutical

Systems 715,851 598,501 19.6 9.0 10.6

Ophthalmic

Systems 59,721 51,843 15.2 7.9 7.3

TOTAL $2,847,932 $2,552,376 11.6 5.3 6.3

BD DIAGNOSTICS

Preanalytical

Systems $836,422 $746,152 12.1 6.8 5.3

Diagnostic

Systems 770,323 661,004 16.5 11.9 4.6

TOTAL $1,606,745 $1,407,156 14.2 9.2 5.0

BD BIOSCIENCES

Cell

Analysis(1) $646,909 $544,383 18.8 11.9 6.9

Discovery

Labware 218,693 204,692 6.8 1.7 5.1

TOTAL $865,602 $749,075 15.6 9.1 6.5

TOTAL

REVENUES $5,320,279 $4,708,607 13.0 7.1 5.9

(1) Cell Analysis consists of the Immunocytometry Systems and the

Pharmingen units that were previously reported separately.


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Gerbig Engineering Announces Availability of Cleanroom Utility Panel
2. The Palomino Group Announces Launch of Meeting Support Services Business Unit
3. Misys Announces Preliminary Results for the Year Ended 31 May 2008
4. Cardiome Announces Preferred Share Financing
5. Mercy Health Plans Announces New Name for Their Medicare Advantage Plans: Mercy Medicare Advantage
6. American Heart Associations Announces Call for Entries for Howard L. Lewis Achievement Award
7. The Risk Management and Patient Safety Institute Announces 2008/2009 Annual Risk Management Conference, Dates
8. Genesis Pharmaceuticals Announces New Board Member and Forms Committees
9. Fitness Equipment Retailer Fitness 4 Home Superstore Announces New Scottsdale Location
10. Fidelity National Financial, Inc. Announces Opening of Fidelity National Title de Mexico S.A. de C.V.
11. CIHR announces $4.4 million to improve mental health of Canadians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... cardiovascular disease , , THURSDAY, Ja...the millions of American men and women with type 2...the day may be symptoms of obstructive sleep apnea... one out of three diabetics. , Based on strong ...obal health experts are encouraging physicians to ...
(Date:1/8/2009)...ta receives $20,000 to support local programs as p... , MINNEAPOLIS, Minn., Jan. 8 /PRNewswire-USNews...eived $20,000 in funding to support Project UNIFY ...tional program. Project UNIFY is an initiative to ...an effort to promote school communities where all ...
(Date:1/8/2009)...e the U.S. Food and Drug Administration Drug has q... complex nature of diseases for which new therapeu...inical development times, according to the Tufts C...verage time for the FDA to approve new drugs decli... average clinical phase time means combined clinic...
(Date:1/8/2009)...8 Warner Chilcott Limite...resent at the 27th Annual JP Morgan Conference on ...ting for Warner Chilcott will be Roger Boissonneau... Herendeen, Executive Vice President and Chief Fin...ion will be webcast live for all interested partie...
Breaking Medicine News(10 mins):Health News:Doctors Urged to Screen Diabetics for Sleep Apnea 2Health News:Doctors Urged to Screen Diabetics for Sleep Apnea 3Health News:Special Olympics Minnesota Launches Project UNIFY to Energize Youth 2Health News:New drug development still takes 8 years despite faster FDA review, according to Tufts CSDD 2
...ts why the commonly prescribed cholesterol-lowerin...h, reported by scientists at Wake Forest Universi... the Journal of Clinical Investigation and will ap...had previously been thought that the drug works by...
...ntified common DNA variations that underlie suscep... of the eight genetic alterations the scientists i... smallpox vaccination. A few, however, reduced fev...possibility the same genetic variations linked to ...
...al conference of the European Society of Human Gen...n undergo chromosomal modifications. Ms Tsvia F...spital, Tel Aviv Sourasky Medical Centre, Tel Aviv...hat her teams findings meant that the results of p...
...arch studies focused primarily on men and the resu...n. But we now know that the biological sex and gen...an skin deep. Beginning in 1990, the Society for W...advocacy organization, conveyed to a national audi...
Other Medicine News:Health News:Animal Research Uncovers Another Mechanism of Cholesterol Lowering Drug 2Health News:Genetic Variations Leads to Fever After Smallpox Vaccination 2Health News:Genetic Variations Leads to Fever After Smallpox Vaccination 3Health News:Preimplanted Genetic Screening Should Be Interpreted With Caution 2Health News:Rare Womens Lung Disease May Yield Insights Into Common Diseases 2
(Date:1/7/2009)...D, England, January 7 Circassia Lt...on allergy and critical care, today,announced tha...n 2008 with,its ToleroMune(R) anti-allergy techno...itment for a further phase II clinical trial in ca..., has recruited 120 patients with confirmed,cat a...
(Date:1/6/2009)...gnificance of AHCC for maintaining a healthy immun.../ -- A recently published study in Nutrition and ...Medical University in Osaka, Japan has shown that ...immune function by increasing the number of dendri...system responsible for presenting foreign substanc...
(Date:1/6/2009)... Jan. 6 The Michael J. ...on to four industry research teams for pre-clinica...on,s disease. , , The funding was awarded under...tive. This program, first launched in 2006, suppo...nson,s research. TDI is part of MJFF,s focus on ...
(Date:1/6/2009)..., Mass., Jan. 6 Cequent Pharmaceut...cts to deliver RNAi-based treatments to prevent an...has recently completed a successful toxicology stu... tk RNAi therapeutic targeting the primary oncoge...tous polyposis). FAP is an inherited gastrointesti...
Breaking Medicine Technology:Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Lap Band 26quot 3BTell All 26quot 3B Warns of Patients Becoming Lap Band 26quot 3BOrphans 26quot 3B 25144 1Lap Band 26quot 3BTell All 26quot 3B Warns of Patients Becoming Lap Band 26quot 3BOrphans 26quot 3B 25144 2Lap Band 26quot 3BTell All 26quot 3B Warns of Patients Becoming Lap Band 26quot 3BOrphans 26quot 3B 25144 3Lap Band 26quot 3BTell All 26quot 3B Warns of Patients Becoming Lap Band 26quot 3BOrphans 26quot 3B 25144 4H 26amp 3B S Business Services Offers Parents Tools to Fight Drug Abuse 25140 1H 26amp 3B S Business Services Offers Parents Tools to Fight Drug Abuse 25140 2H 26amp 3B S Business Services Offers Parents Tools to Fight Drug Abuse 25140 3 Dr Robert N Butler Appointed to Board of Directors of BioTime Inc 6990 1 Dr Robert N Butler Appointed to Board of Directors of BioTime Inc 6990 2 Dr Robert N Butler Appointed to Board of Directors of BioTime Inc 6990 3 Dr Robert N Butler Appointed to Board of Directors of BioTime Inc 6990 4Providence Service Corporation Releases Second Quarter Results 25132 1Providence Service Corporation Releases Second Quarter Results 25132 2Providence Service Corporation Releases Second Quarter Results 25132 3Providence Service Corporation Releases Second Quarter Results 25132 4Providence Service Corporation Releases Second Quarter Results 25132 5Providence Service Corporation Releases Second Quarter Results 25132 6Providence Service Corporation Releases Second Quarter Results 25132 7Providence Service Corporation Releases Second Quarter Results 25132 8Providence Service Corporation Releases Second Quarter Results 25132 9Providence Service Corporation Releases Second Quarter Results 25132 10Providence Service Corporation Releases Second Quarter Results 25132 11Providence Service Corporation Releases Second Quarter Results 25132 12
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products: